Ann Wiegand

Low-level viremia persists for at least 7 years in patients on suppressive antiretroviral therapy

Sarah Palmer, Frank Maldarelli, Ann Wiegand et al. · Proceedings of the National Academy of Sciences · 2008 · 646 citations · Full text

Life Sciences, Infectious Diseases, Pharmacology +14

Treatment intensification does not reduce residual HIV-1 viremia in patients on highly active antiretroviral therapy

Jason B. Dinoso, S. Y. Kim, Ann Wiegand et al. · Proceedings of the National Academy of Sciences · 2009 · 445 citations · Full text

Life Sciences, Infectious Diseases, Pharmacotherapy +16

Proviruses with identical sequences comprise a large fraction of the replication-competent HIV reservoir

John Bui, Michele D. Sobolewski, Brandon F. Keele et al. · PLoS Pathogens · 2017 · 257 citations · Full text

Life Sciences, Microbiology, Molecular Biology +17

Immediate antiviral therapy appears to restrict resting CD4 ⁺ cell HIV-1 infection without accelerating the decay of latent infection

Nancie M. Archin, Naveen K. Vaidya, JoAnn D. Kuruc et al. · Proceedings of the National Academy of Sciences · 2012 · 221 citations · Full text

Life Sciences, Immunology, Infectious Diseases +15

Single-cell analysis of HIV-1 transcriptional activity reveals expression of proviruses in expanded clones during ART

Ann Wiegand, Jonathan Spindler, Feiyu Hong et al. · Proceedings of the National Academy of Sciences · 2017 · 179 citations · Full text

Life Sciences, Cell Biology, Microbiology +16